Therapeutic effects of new oximes, benactyzine and atropine in Soman poisoning: Part II. effect of HGG12, HGG42, and obidoxime in poisoning with various anticholinesterase agents in Beagle dogs.
D000818:Animals; D000931:Antidotes / Q000627:therapeutic use*; D001285:Atropine / Q000627:therapeutic use; D002800:Cholinesterase Inhibitors / Q000506:poisoning*; D002802:Cholinesterases / Q000032:analysis; D004285:Dogs; D008297:Male; D009768:Obidoxime Chloride / Q000627:therapeutic use*; D062025:Organophosphate Poisoning; D010091:Oximes / Q000627:therapeutic use*; D010261:Paraoxon / Q000506:poisoning; D011726:Pyridinium Compounds / Q000627:therapeutic use*; D011729:Pyridostigmine Bromide / Q000627:therapeutic use; D012999:Soman / Q000506:poisoning*
D000931:Antidotes; D002800:Cholinesterase Inhibitors; D010091:Oximes; D011726:Pyridinium Compounds; D009768:Obidoxime Chloride; C020166:HGG 42; D001285:Atropine; C020165:HGG 12; D012999:Soman; D002802:Cholinesterases; D011729:Pyridostigmine Bromide; D010261:Paraoxon